⌘K

Login Start Free

Home/Filings/4/0001209191-22-015003

4//SEC Filing

Graves Michael 4

Accession 0001209191-22-015003

CIK 0000827871other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 5:57 PM ET

Size

5.4 KB

Accession

0001209191-22-015003

Insider Transaction Report

Form 4

Period: 2022-02-28

EAGLE PHARMACEUTICALS, INC.EGRX

Director

Transactions

Award
Stock Option (right to buy)
2022-02-28+11,200→ 11,200 total
Exercise: $47.39Exp: 2032-02-28→ Common Stock (11,200 underlying)

Footnotes (1)

[F1]The option fully vests on February 28, 2023, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1

filerCIK 0001339978

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 5:57 PM ET
Size: 5.4 KB

View on SEC.gov